CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+5.62%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$16.5B
AUM Growth
+$861M
(+5.5%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-2.28%
Top 10 Holdings %
Top 10 Hldgs %
30.08%
Holding
747
New
44
Increased
335
Reduced
212
Closed
49
Top Buys
| 1 |
Eli Lilly
LLY
|
$68M |
| 2 |
Qualcomm
QCOM
|
$56.3M |
| 3 |
Nu Holdings
NU
|
$53.7M |
| 4 |
Amazon
AMZN
|
$49M |
| 5 |
Banco Macro
BMA
|
$43.2M |
Top Sells
| 1 |
Vipshop
VIPS
|
$599M |
| 2 |
Apple
AAPL
|
$46.1M |
| 3 |
Adobe
ADBE
|
$41.4M |
| 4 |
Starbucks
SBUX
|
$30M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$28.3M |
Sector Composition
| 1 | Technology | 33% |
| 2 | Healthcare | 27.47% |
| 3 | Financials | 9.69% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
651
A.O. Smith
AOS
$10.3B
| – | – |
0
| – | -$512K |
|
652
Ardelyx
ARDX
$1.57B
| – | – |
-230,000
| Closed | -$1.68M |
|
653
Avery Dennison
AVY
$13.1B
| – | – |
-1,522
| Closed | -$340K |
|
654
Cabaletta Bio
CABA
$155M
| – | – |
-200,000
| Closed | -$3.41M |
|
655
Crinetics Pharmaceuticals
CRNX
$3.35B
| – | – |
-88,005
| Closed | -$4.12M |
|
656
New Oriental
EDU
$7.98B
| – | – |
-11,700
| Closed | -$7.99M |
|
657
EPAM Systems
EPAM
$9.44B
| – | – |
-2,707
| Closed | -$748K |
|
658
EPR Properties
EPR
$4.05B
| – | – |
-91,196
| Closed | -$3.87M |
|
659
Evolent Health
EVH
$1.11B
| – | – |
-185,228
| Closed | -$6.07M |
|
660
4D Molecular Therapeutics
FDMT
$340M
| – | – |
-269,000
| Closed | -$8.57M |
|
661
Amicus Therapeutics
FOLD
$2.46B
| – | – |
-799,823
| Closed | -$9.42M |
|
662
Haemonetics
HAE
$2.62B
| – | – |
-5,316
| Closed | -$454K |
|
663
Howard Hughes
HHH
$4.69B
| – | – |
-84,946
| Closed | -$5.88M |
|
664
Ingredion
INGR
$8.24B
| – | – |
-2,000
| Closed | -$234K |
|
665
Disc Medicine
IRON
$2.11B
| – | – |
-80,000
| Closed | -$4.98M |
|
666
KalVista Pharmaceuticals
KALV
$796M
| – | – |
-350,000
| Closed | -$4.15M |
|
667
KB Home
KBH
$4.63B
| – | – |
-6,301
| Closed | -$447K |
|
668
Li Auto
LI
$24B
| – | – |
-55,000
| Closed | -$1.67M |
|
669
Madrigal Pharmaceuticals
MDGL
$9.65B
| – | – |
-18,000
| Closed | -$4.81M |
|
670
News Corp Class A
NWSA
$16.6B
| – | – |
0
| – | -$5.58M |
|
671
Pacira BioSciences
PCRX
$1.19B
| – | – |
-181,901
| Closed | -$5.32M |
|
672
Penumbra
PEN
$11B
| – | – |
-16,171
| Closed | -$3.61M |
|
673
Progyny
PGNY
$1.94B
| – | – |
-94,056
| Closed | -$3.59M |
|
674
Phreesia
PHR
$1.68B
| – | – |
-177,939
| Closed | -$4.26M |
|
675
Power Integrations
POWI
$2.52B
| – | – |
-71,826
| Closed | -$5.14M |
|